CIC-REARRANGED SARCOMA
Clinical trials for CIC-REARRANGED SARCOMA explained in plain language.
Never miss a new study
Get alerted when new CIC-REARRANGED SARCOMA trials appear
Sign up with your email to follow new studies for CIC-REARRANGED SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with spread sarcoma: drug cocktail trial launches
Disease control OngoingThis study tests whether adding three drugs (vincristine, irinotecan, regorafenib) to standard chemotherapy helps people with newly diagnosed Ewing sarcoma that has spread. About 437 participants aged 1 to 50 will receive either the new combo or standard treatment. The goal is to…
Matched conditions: CIC-REARRANGED SARCOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 26, 2026 10:11 UTC
-
New drug shows promise in slowing rare bone cancers
Disease control OngoingThis study tests whether the drug regorafenib can slow or stop the growth of bone sarcomas that have spread to other parts of the body. About 163 adults with advanced osteosarcoma, Ewing sarcoma, chondrosarcoma, or chordoma will receive either regorafenib or a placebo. The main g…
Matched conditions: CIC-REARRANGED SARCOMA
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 26, 2026 10:02 UTC
-
New drug trial aims to tame rare sarcomas
Disease control OngoingThis early-stage study tests a drug called BTX-A51 in 24 people with advanced liposarcoma that has spread or come back. The main goal is to check if the drug is safe and tolerable at two different doses. Researchers will also watch for any tumor shrinkage or slowing of the diseas…
Matched conditions: CIC-REARRANGED SARCOMA
Phase: PHASE1 • Sponsor: Michael Wagner, MD • Aim: Disease control
Last updated May 20, 2026 11:56 UTC